INHALE-3 Study Highlights the Efficacy of Inhaled Insulin Over Usual Care for Type 1 Diabetes
Jun 23, 2024
Diabetes Investment Portfolios
Initial Results of INHALE-3 Study: Afrezza® vs. Conventional Insulin Delivery
Mar 12, 2024
Biomea Fusion Reports Promising Results for Diabetes Treatment Candidate BMF-219 at WCIRDC
Dec 8, 2023